| FSMAX | VRMGX | FSMAX / VRMGX | |
| Total Expense Ratio | 0.04 | 0.83 | 4% |
| Annual Report Gross Expense Ratio | 0.04 | 0.92 | 4% |
| Fund Existence | 14 years | 8 years | - |
| Gain YTD | 3.050 | -5.465 | -56% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 40.6B | 553M | 7,342% |
| Annual Yield % from dividends | 0.56 | 0.00 | - |
| Returns for 1 year | 10.51 | -38.85 | -27% |
| Returns for 3 years | 48.06 | -23.72 | -203% |
| Returns for 5 years | 19.23 | -45.51 | -42% |
| Returns for 10 years | 157.02 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ROBO | 72.86 | 0.44 | +0.61% |
| Robo Global® Robotics&Automation ETF | |||
| JULW | 39.31 | -0.08 | -0.20% |
| AllianzIM US Equity Buffer20 Jul ETF | |||
| QDVO | 28.72 | -0.20 | -0.69% |
| Amplify CWP Growth & Income ETF | |||
| STXD | 37.53 | -0.35 | -0.91% |
| Strive 1000 Dividend Growth ETF | |||
| THNR | 25.65 | -0.72 | -2.73% |
| Amplify Weight Loss Drug & Treatment ETF | |||